Premium
Low FCMR mRNA expression in leukocytes of patients with Kawasaki disease six months after disease onset
Author(s) -
Chang LingSai,
Guo Mindy MingHuey,
Yan JiaHuei,
Huang YingHsien,
Lo MaoHung,
Kuo HoChang
Publication year - 2020
Publication title -
pediatric allergy and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.269
H-Index - 89
eISSN - 1399-3038
pISSN - 0905-6157
DOI - 10.1111/pai.13235
Subject(s) - kawasaki disease , medicine , antibody , peripheral blood mononuclear cell , immunology , immune system , receptor , immunoglobulin g , messenger rna , gastroenterology , artery , gene , biology , in vitro , biochemistry
Background Immunoglobulin (Ig) M plays an important role in immune regulation. FCMR ‐encoded FcμR is a receptor of IgM. Previous research has suggested that IgM levels may be involved in the coronary artery lesions of Kawasaki syndrome or Kawasaki disease (KD). In this study, we aimed to explore the roles of mRNA expressions of IgM receptors, particularly FCMR, in KD patients. FCMR encodes the Fc fragment of immunoglobulin M receptor. Methods We enrolled 60 KD patients and 55 non‐KD controls. Whole‐blood leukocytes were isolated, and the mRNA expression for FCMR was determined. Each mRNA consisted of a sample taken before intravenous immunoglobulin (IVIG) was administered (acute, KD1) and those taken at three weeks, six months, and one year later (KD3, KD4, KD5). Paired KD subjects were analyzed from both the acute and convalescent phases (n = 28). Results After six months and one year of treatment, KD patients still apparently have lower FCMR compared with controls ( P = .004). FCMR expressions were downregulated in male patients with KD prior to IVIG administration ( P = .044). The FCMR of paired KD patients who received IVIG treatments after six months was significantly lower than before undergoing IVIG treatment ( P = .044). Expressions in the polymorphonuclear leukocytes were similar to those in the peripheral blood mononuclear cells. Conclusion The unique data supported that FCMR is expressed by granulocytes at RNA levels in humans and demonstrated lower FCMR six months after the onset of KD. The findings remind us of the need to track the health of children with KD over the long term, even if we think patients have fully recovered.